Evidence map›Paper›PMID 42894867›Full record

ArticleAmerican heart journal plus : cardiology research and practice2026

Dynamic change in soluble suppressor of tumorigenicity 2 (sST

Brian Li, Michaela Dowley, Samantha Langley, Paraic Cliffe, Stephen Whiting, Archana Ganapathy, Anthony D Dimarco, Rossella Barbagallo, Jason N Dungu, Henry Oluwasefunmi Savage

Abstract read
In one paragraph

Article in American heart journal plus : cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brian LiMid and South Essex NHS Foundation Trust, United Kingdom.
Michaela DowleyMid and South Essex NHS Foundation Trust, United Kingdom.
Samantha LangleyMid and South Essex NHS Foundation Trust, United Kingdom.
Paraic CliffeMid and South Essex NHS Foundation Trust, United Kingdom.
Stephen WhitingMid and South Essex NHS Foundation Trust, United Kingdom.
Archana GanapathyMid and South Essex NHS Foundation Trust, United Kingdom.
Anthony D DimarcoMid and South Essex NHS Foundation Trust, United Kingdom.
Rossella BarbagalloMid and South Essex NHS Foundation Trust, United Kingdom.
Jason N DunguMid and South Essex NHS Foundation Trust, United Kingdom.
Henry Oluwasefunmi SavageMid and South Essex NHS Foundation Trust, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: To evaluate the association of soluble suppression of tumorigenicity 2 (sST Methods: Paired sST Results: The median age was 71.5 years (IQR 62-80.8), 39 (23.2%) were women, median LVEF was 26% (IQR 17.5-32.5), and 158 (94.1%) had NYHA class III or IV symptoms. During one-year follow-up, 34 patients (20.2%) died. Each doubling of decompensation sST Conclusion: Elevated sST

Indexed as

BiomarkerHeart failurePrognosisSoluble ST2

Identifiers

PMID42894867
PMCPMC13677174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.